文献速递生殖医学产科

产前汞暴露与性早熟:前瞻性出生队列研究

Prenatal exposure to mercury and precocious puberty: a prospective birth cohort study.
PubMed 文献 · Hum Reprod · 2021-01-01

该研究基于波士顿出生队列1512对母婴,随访至21岁,发现母亲产后1-3天红细胞汞浓度最高三分位与性早熟风险增加相关(调整HR 2.41, 95%CI 1.16-5.03)。合并母亲心血管代谢疾病及不良出生结局时风险更高(HR 4.76, 95%CI 1.66-13.60)。

要点

  • 产前高汞暴露与性早熟风险增加相关,最高三分位调整HR为2.41。
  • 母亲心血管代谢疾病及不良出生结局可增强汞暴露的性早熟风险。

核心结论

  • 产前高汞暴露与性早熟风险增加相关,合并母亲心血管代谢疾病及不良出生结局时风险进一步增强。

研究设计与样本

  • 前瞻性出生队列研究,纳入波士顿出生队列1512对母婴,2002-2013年入组,随访至21岁。
  • 产前暴露以分娩后1-3天母亲红细胞汞浓度评估;性早熟依据ICD编码定义。

主要发现

  • 性早熟组与非性早熟组母亲汞浓度中位数(四分位距)分别为3.4(1.9-4.6)µg/l和2.0(1.0-3.7)µg/l。
  • 与最低三分位相比,最高三分位汞暴露的性早熟调整HR为2.41(95%CI 1.16-5.03)。
  • 同时具有不良出生结局和母亲高红细胞汞浓度及心血管代谢疾病的儿童,性早熟HR为4.76(95%CI 1.66-13.60)。

临床怎么用

  • 对产前高汞暴露尤其合并母亲心血管代谢疾病或不良出生结局的儿童,应关注性早熟风险并加强随访。

局限性

  • 性早熟基于医疗记录定义而非直接评估,可能导致漏诊且无法进行亚分类。
  • 研究人群以城市低收入少数族裔为主,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is in utero exposure to mercury associated with the risk of precocious puberty? SUMMARY ANSWER: Prenatal exposure to high levels of mercury was associated with increased risk of precocious puberty, which was strengthened by concomitant maternal cardiometabolic conditions and adverse birth outcomes. WHAT IS KNOWN ALREADY: The developing fetus is sensitive to mercury, a well-known endocrine disruptor which impacts the endocrine and reproductive system. STUDY DESIGN, SIZE, DURATION: This study included 1512 mother-child pairs from the Boston Birth Cohort, a longitudinal cohort which recruited at birth and followed prospectively up to 21 years of age. PARTICIPANTS/MATERIALS, SETTING, METHODS: Mother-child pairs, from a predominantly urban minority population, were enrolled from 2002 to 2013. Prenatal exposure was assessed by maternal mercury concentration in red blood cells (RBCs) collected at 1-3 days after delivery. Precocious puberty was defined based on International Classification of Disease codes. Cox proportional hazards models were applied to the association between maternal mercury concentrations and the risk of precocious puberty. MAIN RESULTS AND THE ROLE OF CHANCE: The median (interquartile range) of maternal mercury concentrations among children with and without precocious puberty were 3.4 (1.9-4.6) µg/l and 2.0 (1.0-3.7) µg/l, respectively. Compared to those in the lowest tertile for mercury, the highest tertile was associated with increased risk of precocious puberty, with an adjusted hazard ratio (HR) of 2.41, 95% CI: 1.16-5.03. In addition, concomitant maternal cardiometabolic conditions and adverse birth outcomes strengthened the effects of mercury on the risk of precocious puberty. The highest risk of precocious puberty was observed among children who had adverse birth outcomes and whose mothers had high RBC-mercury concentrations along with cardiometabolic conditions, with an HR of 4.76 (95% CI: 1.66-13.60) compared to children with favorable profiles of all three risk factors. LIMITATIONS, REASONS FOR CAUTION: Precocious puberty was defined based on medical records, not on a direct assessment, which may have led to underdiagnosis and the inability to make a subclassification. The study included a predominately urban, low-income, minority population and as such our findings may not be widely generalizable. WIDER IMPLICATIONS OF THE FINDINGS: Prenatal Hg exposure was associated with an increased risk of precocious puberty. This risk was strengthened by concomitant maternal cardiometabolic conditions during pregnancy and adverse birth outcomes. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the NIH/National Institute of Environmental Health Sciences, NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Health Resources and Services Administration of the U.S. Department of Health and Human Services. The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Wang G, Tang WY, Ji H, et al. Prenatal exposure to mercury and precocious puberty: a prospective birth cohort study. Hum Reprod. 2021. PMID: 33367618. doi:10.1093/humrep/deaa315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。